Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
Feb 2017
|
JAMA Oncol
|
|
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
|
Feb 2017
|
Lancet Haematol
|
myelodysplastic syndromes (MDS)
|
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.
|
Feb 2017
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis
|
Feb 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
Stem and progenitor cell alterations in myelodysplastic syndromes
|
Feb 2017
|
Blood
|
myelodysplastic syndromes (MDS)
|
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
|
Feb 2017
|
Oncotarget
|
myelodysplastic syndromes (MDS)
|
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications
|
Feb 2017
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India.
|
Feb 2017
|
Indian J Hematol Blood Transfus
|
aplastic anemia
|
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
|
Feb 2017
|
Mediterr J Hematol Infect Dis
|
myelodysplastic syndromes (MDS)
|
Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.
|
Feb 2017
|
Haematologica
|
myelodysplastic syndromes (MDS)
|